|
US4576957A
(en)
*
|
1984-07-05 |
1986-03-18 |
American Cyanamid Company |
N-(Substituted phenyl)-N'-[(1H-imidazol-1-yl) and (1H-1,2,4-triazol-1-yl)alkyl]ureas
|
|
US5017584A
(en)
*
|
1984-12-20 |
1991-05-21 |
Sterling Drug Inc. |
Antidepressant 2-(4,5-dihydro-1H-imidazolyl)-dihydro-1H-indoles, -1,2,3,4-tetrahydroquinolines and -1H-indoles, and methods of use thereas
|
|
US4902505A
(en)
*
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
|
IT1222563B
(it)
*
|
1986-09-30 |
1990-09-05 |
Brasil Compressores Sa |
Compressore ermetico ad albero a gomiti orizzontale
|
|
US5004697A
(en)
*
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
|
US4933324A
(en)
*
|
1988-02-26 |
1990-06-12 |
Shashoua Victor E |
Fatty acid-neuroactive drug conjugate as a prodrug
|
|
US5527527A
(en)
*
|
1989-09-07 |
1996-06-18 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
|
|
US5112596A
(en)
*
|
1990-04-23 |
1992-05-12 |
Alkermes, Inc. |
Method for increasing blood-brain barrier permeability by administering a bradykinin agonist of blood-brain barrier permeability
|
|
US5185248A
(en)
*
|
1990-05-08 |
1993-02-09 |
E. R. Squibb & Sons, Inc. |
Farnesyl-protein transferase assay for identifying compounds that block neoplastic transformation
|
|
US5633376A
(en)
*
|
1990-12-28 |
1997-05-27 |
Neurogen Corporation |
Certain aminomethyl phenylimidazole derivatives; and 4-aryl substituted piperazinyl and piperidinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype ligands
|
|
US5614560A
(en)
*
|
1991-04-04 |
1997-03-25 |
Children's Medical Center Corporation |
Method of preventing NMDA receptor-mediated neuronal damage
|
|
US5322950A
(en)
*
|
1991-12-05 |
1994-06-21 |
Warner-Lambert Company |
Imidazole with angiotensin II antagonist properties
|
|
GB2267966A
(en)
*
|
1992-06-17 |
1993-12-22 |
Merck & Co Inc |
A fluorescence assay for farnesyl protein transferase activity
|
|
US5726197A
(en)
*
|
1992-11-02 |
1998-03-10 |
Syntex (U.S.A.) Inc. |
Isoindolinyl derivatives
|
|
US5523317A
(en)
*
|
1993-07-05 |
1996-06-04 |
Nippon Chemiphar Co., Ltd. |
Method of reducing blood pressure
|
|
US5719148A
(en)
*
|
1993-10-15 |
1998-02-17 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
|
US6365588B1
(en)
*
|
1993-10-15 |
2002-04-02 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
US5576437A
(en)
*
|
1993-12-17 |
1996-11-19 |
The Procter & Gamble Company |
7-(2-imidazolnylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists
|
|
DK0736020T3
(da)
*
|
1993-12-17 |
2000-08-07 |
Procter & Gamble |
6-(2-imidazolinylamino)quinolinforbindelser, der er egnede som alfa-2-adrenoceptoragonister
|
|
US5616601A
(en)
*
|
1994-07-28 |
1997-04-01 |
Gd Searle & Co |
1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
|
|
US5856326A
(en)
*
|
1995-03-29 |
1999-01-05 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
GB9515975D0
(en)
*
|
1995-08-04 |
1995-10-04 |
Zeneca Ltd |
Chemical compounds
|
|
SK283335B6
(sk)
*
|
1995-12-08 |
2003-06-03 |
Janssen Pharmaceutica N. V. |
(Imidazol-5-yl)metyl-2-chinolinónové deriváty, spôsob a medziprodukty na ich prípravu, ich použitie a farmaceutické kompozície na ich báze
|
|
US5874442A
(en)
*
|
1995-12-22 |
1999-02-23 |
Schering-Plough Corporation |
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
|
|
US6011029A
(en)
*
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
|
US5859012A
(en)
*
|
1996-04-03 |
1999-01-12 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
TW436484B
(en)
*
|
1996-04-24 |
2001-05-28 |
Dev Center Biotechnology |
1,2,3,4-tetrahydroisoquinoline derivatives having a nitrogen-containing heterocyclic methyl substituent, the preparation process and pharmaceutical composition thereof
|
|
FR2757855B1
(fr)
*
|
1996-12-30 |
1999-01-29 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6013662A
(en)
*
|
1996-12-30 |
2000-01-11 |
Rhone-Poulenc Rorer S.A. |
Farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments
|
|
TW591030B
(en)
*
|
1997-03-10 |
2004-06-11 |
Janssen Pharmaceutica Nv |
Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
|
|
RU2205831C2
(ru)
*
|
1997-04-25 |
2003-06-10 |
Янссен Фармацевтика Н.В. |
Хиназолиноны, ингибирующие фарнезилтрансферазу
|
|
US6060038A
(en)
*
|
1997-05-15 |
2000-05-09 |
Merck & Co., Inc. |
Radiolabeled farnesyl-protein transferase inhibitors
|
|
AU740603B2
(en)
*
|
1997-06-02 |
2001-11-08 |
Janssen Pharmaceutica N.V. |
(imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
|
|
US6358968B1
(en)
*
|
1997-06-17 |
2002-03-19 |
Schering Corporation |
N-substituted urea inhibitors of farnesyl-protein transferase
|
|
TW527355B
(en)
*
|
1997-07-02 |
2003-04-11 |
Bristol Myers Squibb Co |
Inhibitors of farnesyl protein transferase
|
|
US6387903B1
(en)
*
|
1997-08-27 |
2002-05-14 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
WO1999026657A1
(en)
*
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
|
AU1767599A
(en)
*
|
1997-12-23 |
1999-07-19 |
Aventis Pharma S.A. |
Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines
|
|
AU2578499A
(en)
*
|
1998-02-03 |
1999-08-16 |
Continental Pet Technologies, Inc. |
Enhanced oxygen-scavenging polymers, and packaging made therefrom
|
|
JP2002519428A
(ja)
*
|
1998-07-02 |
2002-07-02 |
メルク エンド カムパニー インコーポレーテッド |
プレニル−タンパク質トランスフェラーゼの阻害剤
|
|
ID26987A
(id)
*
|
1998-07-06 |
2001-02-22 |
Janssen Pharmaceutica Nv |
Inhibitor-inhibitor transferase protein farnesil dengan sifat-sifat peka terhadap sinar radiasi in vivo
|
|
HRP20000904A2
(en)
*
|
1998-07-06 |
2001-12-31 |
Janssen Pharmaceutica Nv |
Farnesyl protein transferase inhibitors for treating arthropathies
|
|
US6338092B1
(en)
*
|
1998-09-24 |
2002-01-08 |
International Business Machines Corporation |
Method, system and computer program for replicating data in a distributed computed environment
|
|
US20020064142A1
(en)
*
|
1998-10-13 |
2002-05-30 |
Franklin P. Antonio |
Base station architecture
|
|
PL349839A1
(en)
*
|
1999-02-11 |
2002-09-23 |
Pfizer Prod Inc |
Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
|
|
US6328988B1
(en)
*
|
1999-04-23 |
2001-12-11 |
Rutgers, The State University Of New Jersey |
Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules
|
|
JP5491681B2
(ja)
*
|
2000-02-04 |
2014-05-14 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
乳ガンの治療のためのファルネシルタンパク質トランスフェラーゼ阻害剤
|
|
US20020052380A1
(en)
*
|
2000-02-18 |
2002-05-02 |
Dinsmore Christopher J. |
Inhibitors of prenyl-protein transferase
|
|
US20020010184A1
(en)
*
|
2000-02-18 |
2002-01-24 |
Dinsmore Christopher J. |
Inhibitors of prenyl-protein transferase
|
|
US6838467B2
(en)
*
|
2000-02-24 |
2005-01-04 |
Janssen Pharmaceutica N. V. |
Dosing regimen
|
|
JP2003525252A
(ja)
*
|
2000-02-29 |
2003-08-26 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Ｈｅｒ２抗体とのファルネシルタンパク質トランスフェラーゼ阻害剤組み合わせ剤
|
|
US20030078281A1
(en)
*
|
2000-02-29 |
2003-04-24 |
Rybak Mary Ellen Margaret |
Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents
|
|
US20030027808A1
(en)
*
|
2000-02-29 |
2003-02-06 |
Palmer Peter Albert |
Farnesyl protein transferase inhibitor combinations with platinum compounds
|
|
WO2001064194A2
(en)
*
|
2000-02-29 |
2001-09-07 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with camptothecin compounds
|
|
AU2001252147A1
(en)
*
|
2000-02-29 |
2001-09-12 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations
|
|
EP2133078A1
(en)
*
|
2000-03-03 |
2009-12-16 |
Eisai R&D Management Co., Ltd. |
Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments
|
|
TWI310684B
(en)
*
|
2000-03-27 |
2009-06-11 |
Bristol Myers Squibb Co |
Synergistic pharmaceutical kits for treating cancer
|
|
US20010051642A1
(en)
*
|
2000-04-17 |
2001-12-13 |
Kyunghye Ahn |
Method for treating Alzheimer's disease
|
|
US6844357B2
(en)
*
|
2000-05-01 |
2005-01-18 |
Pfizer Inc. |
Substituted quinolin-2-one derivatives useful as antiproliferative agents
|
|
CA2410415A1
(en)
*
|
2000-06-23 |
2002-01-03 |
E.I. Du Pont De Nemours And Company |
Steam distribution ring for spinning machines
|
|
US7279080B2
(en)
*
|
2000-07-27 |
2007-10-09 |
City Technology Limited |
Gas sensors
|
|
WO2002024682A1
(en)
*
|
2000-09-25 |
2002-03-28 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors
|
|
US7173040B2
(en)
*
|
2000-09-25 |
2007-02-06 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derinazoline derivatives
|
|
WO2002024686A2
(en)
*
|
2000-09-25 |
2002-03-28 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
|
|
GB0023915D0
(en)
*
|
2000-09-29 |
2000-11-15 |
Inst Of Ophthalmology |
Treatment of neuroinflammatory disease
|
|
DK1339407T3
(da)
*
|
2000-11-28 |
2006-08-14 |
Janssen Pharmaceutica Nv |
Farnesylproteintransferaseinhibitorer til behandling af inflammatorisk tarmsygdom
|
|
CA2432137C
(en)
*
|
2000-12-19 |
2010-12-21 |
Pfizer Products Inc. |
Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1h-quinolin-2-one, 2,3-dihydroxybutanedioate salts and method of production
|
|
WO2002056884A2
(en)
*
|
2001-01-22 |
2002-07-25 |
Schering Corporation |
Treatment of malaria with farnesyl protein transferase inhibitors
|
|
BRPI0208075B8
(pt)
*
|
2001-03-12 |
2021-05-25 |
Janssen Pharmaceutica Nv |
processo para a preparação de compostos de imidazol
|
|
IL157443A0
(en)
*
|
2001-03-14 |
2004-03-28 |
Bristol Myers Squibb Co |
Pharmaceutical compositions for the treatment of cancer including an epothilone analog and a chemotherapeutic agent
|
|
US20020151563A1
(en)
*
|
2001-03-29 |
2002-10-17 |
Pfizer Inc. |
Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the inhibition of abnormal cell growth
|
|
WO2002080895A2
(en)
*
|
2001-04-06 |
2002-10-17 |
Schering Corporation |
Treatment of malaria with farsenyl protein transferase inhibitors
|
|
US6939564B2
(en)
*
|
2001-06-08 |
2005-09-06 |
Labopharm, Inc. |
Water-soluble stabilized self-assembled polyelectrolytes
|
|
US6740757B2
(en)
*
|
2001-08-29 |
2004-05-25 |
Pfizer Inc |
Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1h-quinolin-2-one and salts thereof, useful in the treatment of cancer
|
|
CA2468996A1
(en)
*
|
2001-12-03 |
2003-06-12 |
Schering Corporation |
Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
|
|
AU2002364537A1
(en)
*
|
2001-12-07 |
2003-06-23 |
Regents Of The University Of Michigan |
Prospective identification and characterization of breast cancer stem cells
|
|
DK1469729T3
(en)
*
|
2002-01-18 |
2016-01-25 |
Lonza Ag |
VIRUS KILLING DISINFECTANT
|
|
US6837693B2
(en)
*
|
2002-01-31 |
2005-01-04 |
Ashear, Ltd. |
Fluid-pumping system employing piston-driven pump and employing at least one pulsation dampener
|
|
US6974818B2
(en)
*
|
2002-03-01 |
2005-12-13 |
Euro-Celtique S.A. |
1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
|
|
US20030050323A1
(en)
*
|
2002-08-28 |
2003-03-13 |
Rybak Mary Ellen Margaret |
Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives
|
|
US20030060480A1
(en)
*
|
2002-08-28 |
2003-03-27 |
Horak Ivan David |
Farnesyl protein transferase inhibitor combinations with vinca alkaloids
|
|
US7082558B2
(en)
*
|
2002-11-25 |
2006-07-25 |
Texas Instruments Incorporated |
Increasing possible test patterns which can be used with sequential scanning techniques to perform speed analysis
|
|
UA81790C2
(uk)
*
|
2002-12-19 |
2008-02-11 |
Фармация Италия С.П.А. |
Заміщені піролопіразольні похідні як інгібітори кінази
|
|
WO2004103352A1
(en)
*
|
2003-05-23 |
2004-12-02 |
Ramot At Tel Aviv University, Ltd. |
Ras antagonists for treating neurodegenerative disorders
|
|
US20050089502A1
(en)
*
|
2003-08-21 |
2005-04-28 |
Todd Schansberg |
Effervescent delivery system
|
|
US20050089515A1
(en)
*
|
2003-08-29 |
2005-04-28 |
Dyax Corp. |
Poly-pegylated protease inhibitors
|
|
EP1626339B1
(en)
*
|
2004-08-13 |
2016-02-24 |
Sap Se |
Data processing system and method for assigning objects to processing units
|
|
JPWO2006006730A1
(ja)
*
|
2004-07-15 |
2008-05-01 |
株式会社ニコン |
平面モータ装置、ステージ装置、露光装置及びデバイスの製造方法
|
|
CA2575466A1
(en)
*
|
2004-08-13 |
2006-02-23 |
Genentech, Inc. |
Thiazole based inhibitors of atp-utilizing enzymes
|
|
HRP20130399T1
(hr)
*
|
2004-11-05 |
2013-06-30 |
Janssen Pharmaceutica Nv |
Terapeutska upotreba inhibitora farenziltransferaze i postupci praä†enja njihove efikasnosti
|
|
US20080002621A1
(en)
*
|
2006-06-29 |
2008-01-03 |
Boris Ginzburg |
Reliable multicast techniques for wireless links
|
|
US20090036275A1
(en)
*
|
2007-07-31 |
2009-02-05 |
Chi-Chang Hsiao |
Power-Supplying and Shock-Absorbing Device for an Exerciser
|